Nike Shox Ride 2 Surfaces in Mineral Slate
Nike brings the Shox Ride 2 back into rotation with a restrained colorway that proves the early-2000s platform thrives when design restraint takes precedence over visual noise. The Mineral Slate edition opts for muted earth tones and strategic accent work rather than the bright column treatments that defined much of the Shox legacy.
By Jordan Ellis
The Nike Shox Ride 2 has long occupied an understated corner of the Shox catalog, one tier below the cultural dominance of the R4 and TL variants, yet no less worthy of sustained rotation. This new Mineral Slate offering demonstrates why the Ride 2 deserves renewed attention—it simply executes better when given purposeful colorway direction.
The foundation sits in a subdued Mineral Slate tone, paired with Steam green TPU overlays that add subtle dimension without overwhelming the silhouette. Textured black leather reinforces the refined approach, while the signature Shox columns and forefoot Air units fade into a matching black rather than standing as visual centerpieces. The result is a sneaker that reads as cohesive and intentional, design choices that align with contemporary taste for restrained sportswear.
Design & Materials
This colorway exemplifies a larger trend in vintage Nike reissues: letting material quality and proportion do the talking. The Shox Ride 2's construction—from its cushioning architecture to its TPU paneling—benefits from this tonal discipline. Mineral Slate functions as a neutral canvas, allowing the textural interplay between leather and synthetic components to become the focal point rather than color blocking.
Nike under retail
Browse Nike items priced below retail on StockX
Release Info
Product: Nike Shox Ride 2 "Mineral Slate"
SKU: IR0047-300
Release Date: Summer 2026
Retail Price: $190
Availability: Nike and select retailers
The $190 entry point positions this within standard Nike Shox pricing. For context, secondary market activity on earlier Shox Ride 2 releases has shown significant volatility—recent deal tracking captured the model at sharp discounts, so patient buyers may see opportunities emerge post-launch.
